{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:49:02Z","timestamp":1793126942756,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40123-020-00308-z","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T13:02:58Z","timestamp":1603371778000},"page":"877-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6710-079X","authenticated-orcid":false,"given":"Mohamud A.","family":"Verjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Brissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9882-7249","authenticated-orcid":false,"given":"Christopher E.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"issue":"3","key":"308_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS\u00a0II definition and classification report. Ocul Surf. 2017;15(3):276\u201383. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008.","journal-title":"Ocul Surf"},{"issue":"2","key":"308_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s1542-0124(12)70081-2","volume":"5","author":"Dry Eye Workshop (DEWS)","year":"2007","unstructured":"Dry Eye Workshop (DEWS). The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5(2):75\u201392. https:\/\/doi.org\/10.1016\/s1542-0124(12)70081-2.","journal-title":"Ocul Surf"},{"issue":"8","key":"308_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","volume":"25","author":"A Behrens","year":"2006","unstructured":"Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25(8):900\u20137. https:\/\/doi.org\/10.1097\/01.ico.0000214802.40313.fa.","journal-title":"Cornea"},{"key":"308_CR4","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.2147\/OPTH.S114674","volume":"10","author":"JM Rynerson","year":"2016","unstructured":"Rynerson JM, Perry HD. DEBS\u2014a unification theory for dry eye and blepharitis. Clin Ophthalmol. 2016;10:2455\u201367. https:\/\/doi.org\/10.2147\/OPTH.S114674.","journal-title":"Clin Ophthalmol"},{"key":"308_CR5","unstructured":"Starr CE. Anterior blepharitis showing scurf. Weill Cornell Medicine, New York; 2020."},{"key":"308_CR6","unstructured":"Starr CE. Anterior blepharitis showing keratinization. Weill Cornell Medicine, New York; 2020."},{"key":"308_CR7","unstructured":"Starr CE. Meibography\u2014showing Meibomian gland dysfunction (MGD). Weill Cornell Medicine, New York; 2020."},{"issue":"2","key":"308_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/s0002-9394(03)00218-6","volume":"136","author":"DA Schaumberg","year":"2003","unstructured":"Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318\u201326. https:\/\/doi.org\/10.1016\/s0002-9394(03)00218-6.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"308_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","volume":"36","author":"PA Rouen","year":"2018","unstructured":"Rouen PA, White ML. Dry eye disease: prevalence, assessment, and management. Home Healthc Now. 2018;36(2):74\u201383. https:\/\/doi.org\/10.1097\/NHH.0000000000000652.","journal-title":"Home Healthc Now"},{"issue":"9","key":"308_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j\/jcrs.2018.06.026","volume":"44","author":"PK Gupta","year":"2018","unstructured":"Gupta PK, Drinkwater OJ, VanDusen KW, Brissette AR, Starr CE. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Cataract Refract Surg. 2018;44(9):1090\u20136. https:\/\/doi.org\/10.1016\/j\/jcrs.2018.06.026.","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"308_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jcrs.2019.03.023","volume":"45","author":"CE Starr","year":"2019","unstructured":"Starr CE, Gupta PK, Farid M, et al. An algorithm for the preoperative diagnosis and treatment of ocular surface disorders. J Cataract Refract Surg. 2019;45(5):669\u201384. https:\/\/doi.org\/10.1016\/j.jcrs.2019.03.023.","journal-title":"J Cataract Refract Surg"},{"key":"308_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","volume":"40","author":"MS Ekker","year":"2017","unstructured":"Ekker MS, Janssen S, Seppi K, et al. Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked. Parkinsonism Relat Disord. 2017;40:1\u201310. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.014.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"308_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.clae.2018.06.003","volume":"41","author":"JS Wolffsohn","year":"2018","unstructured":"Wolffsohn JS, Craig JP, Vidal-Rohr M, Huarte ST, Ah Kit L, Wang M. Blink test enhances ability to screen for dry eye disease. Cont Lens Anterior Eye. 2018;41(5):421\u20135. https:\/\/doi.org\/10.1016\/j.clae.2018.06.003.","journal-title":"Cont Lens Anterior Eye"},{"key":"308_CR14","unstructured":"American Academy of Ophthalmology. Image\u2014fluorescein stain highlighting ocular surface damage. 2020. http:\/\/www.aao.org.  Accessed 14 March 20, 2020."},{"key":"308_CR15","unstructured":"Starr CE. Dry eye disease\u2014fluorescein staining showing localized ocular surface damage. Weill Cornell Medicine, New York; 2020."},{"issue":"7","key":"308_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/ICO.0000000000000464","volume":"34","author":"KS Na","year":"2015","unstructured":"Na KS, Han K, Park YG, Na C, Joo CK. Depression, stress, quality of life, and dry eye disease in Korean women: a population-based study. Cornea. 2015;34(7):733\u20138. https:\/\/doi.org\/10.1097\/ICO.0000000000000464.","journal-title":"Cornea"},{"key":"308_CR17","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","volume":"110","author":"RM Schiffman","year":"2003","unstructured":"Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412\u20139. https:\/\/doi.org\/10.1016\/S0161-6420(03)00462-7.","journal-title":"Ophthalmology"},{"issue":"7","key":"308_CR18","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","volume":"122","author":"F Amparo","year":"2015","unstructured":"Amparo F, Schaumberg DA, Dana R. Comparison of two questionnaires for dry eye symptom assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye. Ophthalmology. 2015;122(7):1498\u2013503. https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.037.","journal-title":"Ophthalmology"},{"issue":"2","key":"308_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","volume":"33","author":"RL Chalmers","year":"2010","unstructured":"Chalmers RL, Begley CG, Caffery B. Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33(2):55\u201360. https:\/\/doi.org\/10.1016\/j.clae.2009.12.010.","journal-title":"Cont Lens Anterior Eye"},{"key":"308_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.exer.2015.08.015","volume":"144","author":"R Karnati","year":"2016","unstructured":"Karnati R, Talla V, Peterson K, Laurie GW. Lacritin and other autophagy associated proteins in ocular surface health. Exp Eye Res. 2016;144:4\u201313. https:\/\/doi.org\/10.1016\/j.exer.2015.08.015.","journal-title":"Exp Eye Res"},{"issue":"6","key":"308_CR21","doi-asserted-by":"publisher","first-page":"BIO168","DOI":"10.1167\/iovs.17-21831","volume":"58","author":"F Amparo","year":"2017","unstructured":"Amparo F, Wang H, Yin J, Marmalidou A, Dana R. Evaluating corneal fluorescein staining using a novel automated method. Invest Ophthalmol Vis Sci. 2017;58(6):BIO168\u201373. https:\/\/doi.org\/10.1167\/iovs.17-21831.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"308_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.7309\/jmtm.3.1.4","volume":"3","author":"JB Chan","year":"2014","unstructured":"Chan JB, Ho HC, Ngah NF, Hussein E. DIY\u2014smartphone slit-lamp adaptor. J Mob Technol Med. 2014;3(1):16\u201322. https:\/\/doi.org\/10.7309\/jmtm.3.1.4.","journal-title":"J Mob Technol Med"},{"issue":"1","key":"308_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaophthalmol.2019.4815","volume":"138","author":"T Inomata","year":"2019","unstructured":"Inomata T, Iwagami M, Nakamura M, et al. Characteristics and risk factors associated with diagnosed and undiagnosed symptomatic dry eye using a smartphone application. JAMA Ophthalmol. 2019;138(1):58\u201368. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.4815.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"308_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ajo.2014.03.002","volume":"157","author":"GN Foulks","year":"2014","unstructured":"Foulks GN, Pflugfelder SC. New testing options for diagnosing and grading dry eye disease. Am J Ophthalmol. 2014;157(6):1122\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2014.03.002.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"308_CR25","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1136\/bjo.2010.185256","volume":"95","author":"L Tong","year":"2011","unstructured":"Tong L, Zhou L, Beuerman RW, Zhao SZ, Li XR. Association of tear proteins with Meibomian gland disease and dry eye symptoms. Br J Ophthalmol. 2011;95(6):848\u201352. https:\/\/doi.org\/10.1136\/bjo.2010.185256.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"308_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clae.2018.09.002","volume":"42","author":"AR Brissette","year":"2019","unstructured":"Brissette AR, Drinkwater OJ, Bohm KJ, Starr CE. The utility of a normal tear osmolarity test in patients presenting with dry eye disease like symptoms: a prospective analysis. Cont Lens Anterior Eye. 2019;42(2):185\u20139. https:\/\/doi.org\/10.1016\/j.clae.2018.09.002.","journal-title":"Cont Lens Anterior Eye"},{"key":"308_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12886-015-0147-3","volume":"15","author":"JH Lee","year":"2015","unstructured":"Lee JH, Lee W, Yoon JH, Seok H, Roh J, Won JU. Relationship between symptoms of dry eye syndrome and occupational characteristics: the Korean National Health and Nutrition Examination Survey 2010-2012. BMC Ophthalmol. 2015;15:147. https:\/\/doi.org\/10.1186\/s12886-015-0147-3.","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"308_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/aos.12985","volume":"94","author":"G van Setten","year":"2016","unstructured":"van Setten G, Labetoulle M, Baudouin C, Rolando M. Evidence of seasonality and effects of psychrometry in dry eye disease. Acta Ophthalmol. 2016;94(5):499\u2013506. https:\/\/doi.org\/10.1111\/aos.12985.","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"308_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1177\/216507990705501004","volume":"55","author":"JR Anshel","year":"2007","unstructured":"Anshel JR. Visual ergonomics in the workplace. AAOHN J. 2007;55(10):414\u201322. https:\/\/doi.org\/10.1177\/216507990705501004.","journal-title":"AAOHN J"},{"key":"308_CR30","unstructured":"American Optometric Association. https:\/\/www.aoa.org\/AOA\/Images\/Patients\/Eye%20Conditions\/20-20-20-rule.pdf. Accessed 14 August 2020."},{"issue":"3","key":"308_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.ajo.2008.05.016","volume":"146","author":"MA Lemp","year":"2008","unstructured":"Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol. 2008;146(3):350\u20136. https:\/\/doi.org\/10.1016\/j.ajo.2008.05.016.","journal-title":"Am J Ophthalmol"},{"key":"308_CR32","doi-asserted-by":"publisher","first-page":"33083","DOI":"10.1038\/srep33083","volume":"6","author":"SH Bae","year":"2016","unstructured":"Bae SH, Shin YJ, Kim HK, Hyon JY, Wee WR, Park SG. Vitamin D supplementation for patients with dry eye syndrome refractory to conventional treatment. Sci Rep. 2016;6:33083. https:\/\/doi.org\/10.1038\/srep33083.","journal-title":"Sci Rep"},{"issue":"4","key":"308_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ICU.0000000000000164","volume":"26","author":"K Duncan","year":"2015","unstructured":"Duncan K, Jeng BH. Medical management of blepharitis. Curr Opin Ophthalmol. 2015;26(4):289\u201394. https:\/\/doi.org\/10.1097\/ICU.0000000000000164.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"308_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5935\/0004-2749.20190097","volume":"82","author":"MVMR Ribeiro","year":"2019","unstructured":"Ribeiro MVMR, Barbosa FT, Ribeiro LEF, Sousa-Rodrigues CF, Ribeiro EAN. Effectiveness of using preservative-free artificial tears versus preserved lubricants for the treatment of dry eyes: a systematic review. Arq Bras Oftalmol. 2019;82(5):436\u201345. https:\/\/doi.org\/10.5935\/0004-2749.20190097.","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"308_CR35","doi-asserted-by":"publisher","first-page":"CD009327","DOI":"10.1002\/14651858.cd009327.pub3","volume":"2","author":"Q Pan","year":"2017","unstructured":"Pan Q, Angelina A, Marrone M, Stark WJ, Akpek EK. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev. 2017;2(2):CD009327. https:\/\/doi.org\/10.1002\/14651858.cd009327.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"308_CR36","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2147\/OPTH.S110557","volume":"10","author":"CP Semba","year":"2016","unstructured":"Semba CP, Gadek TR. Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease. Clin Ophthalmol. 2016;10:1083\u201394. https:\/\/doi.org\/10.2147\/OPTH.S110557.","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"308_CR37","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","volume":"122","author":"J Tauber","year":"2015","unstructured":"Tauber J, Karpecki P, Latkany R, et al. Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: results of the randomized phase III OPUS-2 study. Ophthalmology. 2015;122(12):2423\u201331. https:\/\/doi.org\/10.1016\/j.ophtha.2015.08.001.","journal-title":"Ophthalmology"},{"issue":"8144","key":"308_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/s0140-6736(79)92082-8","volume":"2","author":"DJ Coster","year":"1979","unstructured":"Coster DJ, Shepherd WF, Fook TC, Rice NS, Jones BR. Prolonged survival of corneal allografts in rabbits treated with cyclosporin A. Lancet. 1979;2(8144):688\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(79)92082-8.","journal-title":"Lancet"},{"issue":"5","key":"308_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00003226-199309000-00008","volume":"12","author":"EJ Holland","year":"1993","unstructured":"Holland EJ, Olsen TW, Ketcham JM, et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea. 1993;12(5):413\u20139. https:\/\/doi.org\/10.1097\/00003226-199309000-00008.","journal-title":"Cornea"},{"issue":"10","key":"308_CR40","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/bjo.2005.070888","volume":"89","author":"S Tatlipinar","year":"2005","unstructured":"Tatlipinar S, Akpek EK. Topical ciclosporin in the treatment of ocular surface disorders. Br J Ophthalmol. 2005;89(10):1363\u20137. https:\/\/doi.org\/10.1136\/bjo.2005.070888.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"308_CR41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1080\/14656566.2018.1479742","volume":"19","author":"KG Boboridis","year":"2018","unstructured":"Boboridis KG, Konstas AGP. Evaluating the novel application of cyclosporine 0.1% in ocular surface disease. Expert Opin Pharmacother. 2018;19(9):1027\u201339. https:\/\/doi.org\/10.1080\/14656566.2018.1479742.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"308_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/09273948.2018.1560478","volume":"28","author":"KG Boboridis","year":"2020","unstructured":"Boboridis KG, Kozeis N, Konstas AG. Revisiting ocular allergy: evaluating symptoms, benzalkonium chloride and efficacy of topical ketotifen 0.025. Ocul Immunol Inflamm. 2020;28(2):188\u201390. https:\/\/doi.org\/10.1080\/09273948.2018.1560478.","journal-title":"Ocul Immunol Inflamm"},{"key":"308_CR43","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2147\/OPTH.S136203","volume":"11","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Stinnett SS, Gupta PK. Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients. Clin Ophthalmol. 2017;11:883\u20136. https:\/\/doi.org\/10.2147\/OPTH.S136203.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"308_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.clindermatol.2015.11.009","volume":"34","author":"MM McCusker","year":"2016","unstructured":"McCusker MM, Durrani K, Payette MJ, Suchecki J. An eye on nutrition: the role of vitamins, essential fatty acids, and antioxidants in age-related macular degeneration, dry eye syndrome, and cataract. Clin Dermatol. 2016;34(2):276\u201385. https:\/\/doi.org\/10.1016\/j.clindermatol.2015.11.009.","journal-title":"Clin Dermatol"},{"issue":"4","key":"308_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jtos.2019.08.003","volume":"17","author":"PA Asbell","year":"2019","unstructured":"Asbell PA, Maguire MG, DREAM Study Research Group. Why DREAM should make you think twice about recommending omega-3 supplements. Ocul Surf. 2019;17(4):617\u20138. https:\/\/doi.org\/10.1016\/j.jtos.2019.08.003.","journal-title":"Ocul Surf"},{"issue":"1","key":"308_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jtos.2019.08.002","volume":"18","author":"M Hussain","year":"2020","unstructured":"Hussain M, Shtein RM, Pistilli M, et al. The Dry Eye Assessment and Management (DREAM) extension study\u2014a randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease. Ocul Surf. 2020;18(1):47\u201355. https:\/\/doi.org\/10.1016\/j.jtos.2019.08.002.","journal-title":"Ocul Surf"},{"issue":"2","key":"308_CR47","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/jamaophthalmol.2013.7376","volume":"132","author":"EY Chew","year":"2014","unstructured":"Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, et al. Secondary analyses of the effects of lutein\/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol. 2014;132(2):142\u20139. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.7376.","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00308-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-020-00308-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00308-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T23:47:14Z","timestamp":1634860034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-020-00308-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1007\/s40123-020-00308-z","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"17 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}